Supplemental oxygen therapy
Supplemental oxygen therapy has been studied in 1 paper since 2025: 1 trial in people. The newest paper, Sep 23, 2025: “Procedural learning worsens with OSA severity in older adults and is insensitive to short exposure supplemental oxygen therapy”.
1 paper studies it6 findingsUpdated
See all 1 papers on supplemental oxygen therapy
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Time under 90 % saturation (mean ΔT90 = −8.1 min, p < 0.001) and hypoxic burden (mean ΔHB = −46.9 %min/hr, p < 0.001) both reduced with NOS treatment.”
None of its findings points the other way.
- 1 lab in 1 country
- Funders: National Heart, Lung, and Blood Institute and 4 more
- 6 of 6 findings with company ties
- Human trial1
Studies in people
1 study gave supplemental oxygen therapy to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
no change: Has no effect on procedural learningΔ = −0.4 sequences/30s, CI = [−1.2,0.3] down: Decreases hypoxemiamean ΔT90 = −8.1 min down: Decreases apnea-hypopnea indexCI = [−8.7, −0.7] | Randomized trialtwo nights | 68 peopleclose to half were women (47.7 %)mean 70 yearsCognitively normal men and women aged 65–85 years not currently receiving treatment for OSA | Sleep medicine, Sep 23, 2025 |
What did studies of supplemental oxygen therapy find?
3Studies of supplemental oxygen therapy measured 3 outcomes: apnea-hypopnea index, hypoxemia and procedural learning.
Apnea-hypopnea index
downin humans1
1 study
Apnea-hypopnea index
downin humans1
Supplemental oxygen therapy decreases apnea-hypopnea index in humans (CI = [−8.7, −0.7]).
“The mean NREM AHI was 37.7 events/hour (SD = 20.3) at room air condition compared to 32.9 events/hour (SD = 19.7) at NOS condition (paired T-test, CI = [−8.7, −0.7], p = 0.023, ).”
Human trialtwo nightsn = 68
Sleep medicine
Supplemental oxygen therapy decreases apnea-hypopnea index in humans (participants with OSA severity >15 events/hour or below-median pharyngeal collapsibility).
“we found a significant treatment effect on AHI among participants with OSA severity >15 events/hour or among those with below-median pharyngeal collapsibility.”
Human trialparticipants with OSA severity >15 events/hour or below-median pharyngeal collapsibilitysingle night
Sleep medicine
Hypoxemia
downin humans1
1 study
Hypoxemia
downin humans1
Supplemental oxygen therapy decreases hypoxemia in humans (mean ΔT90 = −8.1 min).
“Time under 90 % saturation (mean ΔT90 = −8.1 min, p < 0.001) and hypoxic burden (mean ΔHB = −46.9 %min/hr, p < 0.001) both reduced with NOS treatment.”
Human trialtwo nightsn = 68
Sleep medicine
Supplemental oxygen therapy decreases hypoxemia in humans (OSA).
“Nocturnal hypoxemia was reduced with NOS treatment.”
Human trialOSAsingle nightn = 65
Sleep medicine
Procedural learning
no changein humans1
1 study
Procedural learning
no changein humans1
Supplemental oxygen therapy showed no clear effect on procedural learning in humans (Δ = −0.4 sequences/30s, CI = [−1.2,0.3]).
“We found no significant difference in the overnight change score of MST or WPA recall under the room-air condition vs NOS condition (paired T-test n = 51, Δ = −0.4 sequences/30s, CI = [−1.2,0.3], p = 0.28 for MST; n = 23, Δ = 1.1 % word pairs recalled, CI = [−7.1,9.3], p = 0.78 for WPA, ).”
Human trialtwo nightsn = 51
Sleep medicine
Supplemental oxygen therapy showed no clear effect on procedural learning in humans (OSA).
“NOS treatment did not improve performance between nights in either the full sample or a responsive sub-group.”
Human trialOSAbrainsingle nightn = 65
Sleep medicine